European Archives - Page 665 of 1588 - European Medical Journal

Semaglutide Reduces Risk of Alzheimer’s Disease

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in people with Type 2 diabetes (T2D).

5 stars

Boehringer, Amgen and Novartis rank top for cardiovascular patient groups

Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups.

Sustainable pharma packaging takes a big step forward

UPM Biochemicals, Selenis and Bormioli Pharma have introduced the pharmaceutical industry’s first bottle made with wood-based PET.

Promising Results for CAR T-Cell Therapy in Relapsed T-Cell Acute Lymphoblastic Leukaemia

A breakthrough study has reported encouraging outcomes using autologous chimeric antigen receptor T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukaemia.

AI Tool to Help Diagnose Type 1 Diabetes Early in Children

Researchers at Cardiff University have developed an AI tool that could help detect signs of Type 1 diabetes in children before they experience dangerous complications.

New Test Simplifies the Diagnosis of Allergies

The Hoxb8 mast cell activation test (Hoxb8 MAT) shows high diagnostic accuracy in identifying peanut allergies.

Geographic Disparities in Liver-related Mortality After COVID-19

Rates of liver-related mortality (LRM) in the USA surged by 19.1% from 2018 to 2021, with substantial state-by-state differences…

New Heart Surgery Risk Revealed: Electrical Complications with Bicuspid Valves

A new study has found that new-onset left bundle-branch block after surgical aortic valve replacement is linked to increased long-term mortality…

Remission Without Glucocorticoids as a SLE Treatment Goal

SLE is a chronic and complex heterogeneous autoimmune disease in which the immune system dysfunctions and inappropriately attacks healthy…

EMJ Rheumatology 11 [Supplement 2] 2024

Systemic lupus erythematosus (SLE), a complex, chronic autoimmune disease, affects around 3.41 million people globally. Two experts…